BioVentrix
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $13M
Investors
- 4
About BioVentrix
BioVentrix develops innovative medical technologies for cardiac repair, particularly addressing heart failure. The company is headquartered in San Ramon, US. Ken Miller serves as the CEO.BioVentrix primarily specializes in innovative medical devices aimed at treating heart conditions, particularly heart failure and ischemic heart disease. Their flagship product, the Revivent TC System, is a unique device designed for the transcatheter repair of the failing heart. This system utilizes a minimally invasive approach to restore the heart's shape and function, thus alleviating symptoms associated with heart failure. The company targets healthcare providers, including hospitals, cardiologists, and cardiac surgeons, who serve patients experiencing severe heart conditions.BioVentrix generates revenue through the sale of its specialized medical devices directly to healthcare institutions. Transactions are primarily structured on a B2B basis, where hospitals and clinics procure devices for use in cardiac procedures. Each transaction may involve a one-time purchase or could include service agreements for device support and maintenance. The pricing structure for the Revivent TC System is aligned with industry standards for high-value medical devices, ensuring that clients receive comprehensive solutions for heart treatment. The company aims to expand its product offerings and penetrate new markets, focusing on regions within North America and Europe where advanced cardiac interventions are increasingly in demand.
Who invested in BioVentrix
4 investors across 1 round
See all investors in BioVentrix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 30, 2023
Amount
$13M
Investors
Questions about BioVentrix
Who invested in BioVentrix?
BioVentrix has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioVentrix raised?
BioVentrix has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioVentrix last raise money?
BioVentrix's most recent round on record is a Series A, in Mar 2023.
What does BioVentrix do?
BioVentrix develops innovative medical technologies for cardiac repair, particularly addressing heart failure.
Where is BioVentrix headquartered?
BioVentrix is headquartered in San Ramon, US.
Which VCs invest in companies like BioVentrix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at BioVentrix's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like BioVentrix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.